Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gynecologic 1

Conditions

Fasting 9Prostatic Neoplasms 3Breast Neoplasms 3Intermittent Fasting 2Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Infertility 1Glioma 1Fibrosis 1Fasting in Malignant Solid Tumors 1Esophageal Neoplasms 1Colorectal Neoplasms 1Childhood Cancer Survivors 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Angptl4 protein, mouse × Clear all
NCT06536881 2025-08-17

GAMMER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Recruiting
30 enrolled
Breast

Breast Neoplasms

NCT03162289 2022-12-13

FIT2

Charite University, Berlin, Germany

Phase NA Unknown
150 enrolled
BreastGynecologic

Breast Neoplasms, Fasting, Ovarian Neoplasms

NCT04330339 2022-07-21

Prolonged Nightly Fasting in Breast Cancer Survivors

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Breast

Breast Neoplasms, Fasting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡